XML 44 R27.htm IDEA: XBRL DOCUMENT
v3.19.1

RESEARCH AND DEVELOPMENT ACTIVITY (Detail Textuals 1) - USD ($) |  | 12 Months Ended |  |
--- | --- | --- | --- | ---
Oct. 03, 2017 | Dec. 31, 2018 | Dec. 31, 2017 | Oct. 29, 2015
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |  |
Common stock, par value (in dollars per share) |  | $ 0.001 | $ 0.001 |
Common stock issued (in shares) |  | 8,719,441 | 8,319,441 |
INKmune License Agreement |  |  |  |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |  |
Percentage of licensor royalty patent grant |  |  |  | 1.00%
University of Pittsburg License Agreement |  |  |  |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |  |
Value of common stock issue | $ 162,634 |  |  |
Common stock, par value (in dollars per share) | $ 7.71 |  |  |
Common stock issued (in shares) | 21,094 |  |  |
Percentage of net sales to pay royalties | 2.50% |  |  |
University of Pittsburg License Agreement | June 26 of each year 2018-2022 | Annual maintenance fees |  |  |  |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |  |
Long-term Commercial Paper |  | $ 5,000 |  |
University of Pittsburg License Agreement | June 26 of each year 2023-2024 | Annual maintenance fees |  |  |  |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |  |
Long-term Commercial Paper |  | 10,000 |  |
University of Pittsburg License Agreement | June 26 of each year 2025 until first commercial sale | Annual maintenance fees |  |  |  |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |  |
Long-term Commercial Paper |  | 25,000 |  |
Immune Ventures to INmune Bio ("Licensee"), ("PITT Agreement"). | Each Phase I initiation |  |  |  |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |  |
Revenue Recognition, Milestone Method, Revenue Recognized |  | $ 50,000 |  |

X
- Definition It represents information about percentage of licensor royalty patent grant. + References No definition available. + Details
Name: | inmb_PercentageOfLicensorRoyaltyPatentGrant
Namespace Prefix: | inmb_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition It represents information about percentage of net sales to pay royalties. + References No definition available. + Details
Name: | inmb_PercentageOfNetSalesToPayRoyalties
Namespace Prefix: | inmb_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesSubscriptions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Including the current and noncurrent portions, carrying value as of the balance sheet date of long-term unsecured obligations issued by corporations and other borrowers to investors (with maturities initially due after one year or beyond the operating cycle if longer). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.16) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.16) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19,20,22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_LongtermCommercialPaperCurrentAndNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of consideration recognized during the period for the milestone or milestones. + References No definition available. + Details
Name: | us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=inmb_InkmuneLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=inmb_UniversityOfPittsburgLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | inmb_CommercialSaleAxis=inmb_FirstCommercialSaleOfEachYearTwoZeroEighteenToTwoZeroTwentyTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=inmb_AnnualMaintenanceFeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | inmb_CommercialSaleAxis=inmb_SecondCommercialSaleOfEachYearTwoZeroTwentyThreeToTwoZeroTwentyFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | inmb_CommercialSaleAxis=inmb_AnnuallyCommercialSaleThereafterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=inmb_ImmuneVenturesToInmuneBioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | inmb_MilestonePaymentsAxis=inmb_MilestonePaymentPhaseOneInitiationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |